Status:
COMPLETED
Analysis of Conjunctival Changes as Indicators for Ab-interno Gelatin Microstent Implantation Surgery Outcomes
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Glaucoma
Glaucoma Open-Angle Primary
Eligibility:
MALE
18-90 years
Phase:
NA
Brief Summary
Trabeculectomy and XEN45 gel stent implantation are glaucoma surgeries that creates an aqueous humor (AH) shunt towards the subconjunctival space (filtration bleb). Once the AH reaches the subconjunct...
Detailed Description
Detailed description Hypothesis * Conjunctival biomarkers may represent a predictive factor to determine the XEN45 and trabeculectomy surgical success and outcomes * A cellular-based analysis may hel...
Eligibility Criteria
Inclusion
- Primary open angle glaucoma
- Written informed consent
- Older than 18 years old
Exclusion
- Patients that don't fully understand the purpose and the postoperative care
- Severe or end-stage glaucoma
- Patients with prior ocular surgery, excluding uncomplicated phacoemulsification 6 months prior to the inclusion in the study
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 17 2022
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04727411
Start Date
January 1 2021
End Date
October 17 2022
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínic - ICOF
Barcelona, Spain, 08028